Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology of Primary Brain and Central Nervous System Tumors in Korea

  • Lee, Chang-Hyun (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Jung, Kyu-Won (Korea Central Cancer Registry, National Cancer Center) ;
  • Yoo, Heon (Neuro-Oncology Clinic, National Cancer Center) ;
  • Park, So-Hee (Korea Central Cancer Registry, National Cancer Center) ;
  • Lee, Seung-Hoon (Neuro-Oncology Clinic, National Cancer Center)
  • Received : 2009.12.28
  • Accepted : 2010.08.03
  • Published : 2010.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : The aim of this report is to provide accurate nationwide epidemiologic data on primary central nervous system (CNS) tumors in Korea. Despite its importance, there are no accurate statistics on primary CNS tumors in Korea. We analyzed primary CNS tumors diagnosed in 2005 from the nationwide registry. Methods : Data on primary CNS tumors diagnosed in 2005 were collected from the Korean Central Cancer Registry and the Korean Brain Tumor Society. Crude and age-standardized rates were calculated in terms of gender, age, and histological type. Tumors of uncertain histology were investigated individually at the corresponding hospitals and had their diagnoses confirmed. Results : A total of 5,692 patients diagnosed with primary CNS tumors in 2005 were included in this study. CNS tumors occurred in females more often than in males (female to male, 1.43 : 1). The most common tumor was meningioma (31.2%). Glioblastoma accounted for 30.7% of all gliomas, and 19.3% of all malignant primary CNS tumors. In children under 19 years of age, both germ cell tumor and embryonal/primitive/medulloblastoma were the most common tumors. Conclusion : This article is the first nationwide primary CNS tumor epidemiology report in Korea. Data from this study should provide valuable information regarding the understanding of primary CNS tumors epidemiology in Korea.

Keywords

References

  1. Annual report of national cancer registration : Cancer incidence in 2005 and survival for 1993-2005. Available at : http://www.iarc.fr/ Accessed September 10, 2008
  2. Bauchet L, Rigau V, Mathieu-Daudé H, Figarella-Branger D, Hugues D, Palusseau L, et al. : French brain tumor data bank : methodology and first results on 10,000 cases. J Neurooncol 84 : 189-199, 2007 https://doi.org/10.1007/s11060-007-9356-9
  3. Central Brain Tumor Registry of the United States. : Statistical report : primary brain tumors diagnosed in the United States in 2004-2005. Available from : http://www.cbtrus.org/ Accessed September 10, 2009
  4. Chi JG, Khang SK : Central nervous system tumors among Koreans : a statistical study of 697 cases. J Korean Med Sci 4 : 77-90, 1989 https://doi.org/10.3346/jkms.1989.4.2.77
  5. Chi JG, Lee HS, Kim MS, Kim CW : Tumors of central nervous system, histological analysis of 327 cases among Koreans. J Korean Cancer Assoc 12 : 3-20, 1980
  6. Committee of Brain Tumor Registry of Japan : Report of Brain Tumor Registry of Japan (1969-1996). Neurol Med Chir (Tokyo) 43 : 1-111, 2003 https://doi.org/10.2176/nmc.43.1
  7. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. : International classification of diseases for oncology Vol 3rd ed. Geneva, Switzerland : World Health Organization, 2000
  8. Hoffman S, Propp JM, McCarthy BJ : Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 8 : 27-37, 2006 https://doi.org/10.1215/S1522851705000323
  9. Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K : Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology 23 : 101-109, 2004 https://doi.org/10.1159/000075952
  10. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N : Trend of brain tumor incidence by histological subtypes in Japan : estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol 60 : 61-69, 2002 https://doi.org/10.1023/A:1020239720852
  11. Kim TS : Clinicopathological study of tumors of the nervous system among Korean. Korean J Pathol 10 : 555-564, 1976
  12. Lee HS, Ham EK, Kim JM, Lee SK : A histological study of tumors of the central nervous system. Korean J Pathol 6 : 157-165, 1972
  13. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. : Nationwide cancer incidence in Korea, 1999-2001; first result using the national cancer incidence database. Cancer Res Treat 37 : 325-331, 2005 https://doi.org/10.4143/crt.2005.37.6.325
  14. Suh YL, Koo H, Kim TS, Chi JG, Park SH, Khang SK, et al. : Tumors of the central nervous system in Korea a multicenter study of 3221 cases. J Neurooncol 56 : 251-259, 2002 https://doi.org/10.1023/A:1015092501279
  15. Wohrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gruber- Mösenbacher U, et al. : The Austrian Brain Tumour Registry : a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95 : 401-411, 2009 https://doi.org/10.1007/s11060-009-9938-9

Cited by

  1. A Consideration ofMGMTGene Promotor Methylation Analysis for Glioblastoma Using Methylation-Specific Polymerase Chain Reaction and Pyrosequencing vol.45, pp.1, 2010, https://doi.org/10.4132/koreanjpathol.2011.45.1.21
  2. Factors Influencing the Response to High Dose Methotrexate-based Vincristine and Procarbazine Combination Chemotherapy for Primary Central Nervous System Lymphoma vol.26, pp.4, 2010, https://doi.org/10.3346/jkms.2011.26.4.551
  3. MGMTGene Promoter Methylation Analysis by Pyrosequencing of Brain Tumour vol.45, pp.5, 2010, https://doi.org/10.4132/koreanjpathol.2011.45.5.455
  4. Mature Cystic Teratoma (Dermoid Cyst) in the Sylvian Fissure : A Case Report and Review of the Literature vol.27, pp.2, 2010, https://doi.org/10.1177/0883073811415681
  5. Population-based survival data for brain tumors in Korea vol.109, pp.2, 2010, https://doi.org/10.1007/s11060-012-0893-5
  6. Lomustine Analogous Drug Structures for Intervention of Brain and Spinal Cord Tumors: The Benefit of In Silico Substructure Search and Analysis vol.2013, pp.None, 2010, https://doi.org/10.1155/2013/360624
  7. Epidemiology of primary brain tumors in childhood and adolescence in Kuwait vol.2, pp.1, 2013, https://doi.org/10.1186/2193-1801-2-58
  8. Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme vol.47, pp.4, 2013, https://doi.org/10.2478/raon-2013-0055
  9. Isolation of mesenchymal stem-like cells in meningioma specimens vol.43, pp.4, 2013, https://doi.org/10.3892/ijo.2013.2053
  10. Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens vol.29, pp.4, 2010, https://doi.org/10.1007/s00381-012-1988-1
  11. An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea vol.1, pp.1, 2013, https://doi.org/10.14791/btrt.2013.1.1.16
  12. Factors affecting functional outcomes in long-term survivors of intracranial germinomas: a 20-year experience in a single institution : Clinical article vol.11, pp.4, 2010, https://doi.org/10.3171/2012.12.peds12336
  13. Epidemiology of Primary CNS Tumors in Iran: A Systematic Review vol.14, pp.6, 2010, https://doi.org/10.7314/apjcp.2013.14.6.3979
  14. The epidemiology of glioma in adults: a “state of the science” review vol.16, pp.7, 2010, https://doi.org/10.1093/neuonc/nou087
  15. Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma vol.5, pp.10, 2010, https://doi.org/10.18632/oncotarget.1975
  16. One-year Survival Rate of Patients with Primary Malignant Central Nervous System Tumors after Surgery in Kazakhstan vol.15, pp.16, 2010, https://doi.org/10.7314/apjcp.2014.15.16.6973
  17. Long-term outcomes in patients with pineal nongerminomatous malignant germ cell tumors treated by radical resection during initial treatment combined with adjuvant therapy vol.157, pp.12, 2015, https://doi.org/10.1007/s00701-015-2614-2
  18. VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment vol.2015, pp.None, 2015, https://doi.org/10.1155/2015/385030
  19. Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors vol.10, pp.None, 2015, https://doi.org/10.1186/s13014-015-0441-5
  20. Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001–2004 from the Brain Tumor Registry of Japan vol.55, pp.4, 2015, https://doi.org/10.2176/nmc.ra.2014-0348
  21. Peritumoral Brain Edema after Stereotactic Radiosurgery for Asymptomatic Intracranial Meningiomas : Risks and Pattern of Evolution vol.58, pp.4, 2015, https://doi.org/10.3340/jkns.2015.58.4.379
  22. Incidence of Primary Spinal Cord, Spinal Meninges, and Cauda Equina Tumors in Korea, 2006-2010 vol.47, pp.2, 2010, https://doi.org/10.4143/crt.2014.017
  23. Understanding the Treatment Strategies of Intracranial Germ Cell Tumors : Focusing on Radiotherapy vol.57, pp.5, 2010, https://doi.org/10.3340/jkns.2015.57.5.315
  24. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis vol.17, pp.6, 2010, https://doi.org/10.1093/neuonc/nou283
  25. Intracranial meningioma surgery in the elderly (over 65 years): prognostic factors and outcome vol.157, pp.9, 2015, https://doi.org/10.1007/s00701-015-2502-9
  26. Development of targeted therapies in treatment of glioblastoma vol.12, pp.3, 2010, https://doi.org/10.7497/j.issn.2095-3941.2015.0020
  27. Self-care Agency and Quality of Life in Brain Tumor Patients after Surgery vol.15, pp.4, 2015, https://doi.org/10.5388/aon.2015.15.4.211
  28. Development of a novel microbubble-liposome complex conjugated with peptide ligands targeting IL4R on brain tumor cells vol.36, pp.1, 2010, https://doi.org/10.3892/or.2016.4836
  29. Brain meningioma in a patient with systemic lupus erythematosus vol.33, pp.2, 2010, https://doi.org/10.12701/yujm.2016.33.2.159
  30. Identification of potential key genes associated with glioblastoma based on the gene expression profile vol.14, pp.2, 2010, https://doi.org/10.3892/ol.2017.6460
  31. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor vol.56, pp.3, 2010, https://doi.org/10.1002/mc.22548
  32. Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997–2014 vol.12, pp.4, 2010, https://doi.org/10.1371/journal.pone.0174439
  33. Molecular Testing of Brain Tumor vol.51, pp.3, 2010, https://doi.org/10.4132/jptm.2017.03.08
  34. An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013 vol.5, pp.1, 2017, https://doi.org/10.14791/btrt.2017.5.1.16
  35. Short-Term Effects of Intensive Inpatient Rehabilitation in Patients with Brain Tumor: a Single-Center Experience vol.11, pp.2, 2010, https://doi.org/10.12786/bn.2018.11.e12
  36. Gamma knife radiosurgery for recurrent gliomas vol.140, pp.3, 2010, https://doi.org/10.1007/s11060-018-2988-0
  37. Epidemiology and Molecular Epidemiology vol.30, pp.1, 2010, https://doi.org/10.1016/j.nec.2018.08.010
  38. Intrathecal Delivery of Folate Conjugated near-Infrared Quantum Dots for Targeted in Vivo Imaging of Gliomas in Mice Brains vol.2, pp.4, 2010, https://doi.org/10.1021/acsabm.8b00629
  39. Genetic and molecular epidemiology of adult diffuse glioma vol.15, pp.7, 2010, https://doi.org/10.1038/s41582-019-0220-2
  40. Population-Based Brain Tumor Survival Analysis via Spatial- and Temporal-Smoothing vol.11, pp.11, 2019, https://doi.org/10.3390/cancers11111732
  41. Elderly Patients with Intracranial Meningioma: Surgical Considerations in 228 Patients with a Comprehensive Analysis of the Literature vol.132, pp.None, 2010, https://doi.org/10.1016/j.wneu.2019.08.150
  42. Histological spectrum of central nervous system lesions at a tertiary care center in India vol.9, pp.5, 2010, https://doi.org/10.4103/ccij.ccij_39_20
  43. Newly-Diagnosed, Histologically-Confirmed Central Nervous System Tumours in a Regional Hospital in Hong Kong : An Epidemiological Study of a 21-Year Period vol.63, pp.1, 2020, https://doi.org/10.3340/jkns.2018.0209
  44. Investigation of the potential anticancer effects of napelline and talatisamine dirterpenes on experimental brain tumor models vol.72, pp.4, 2020, https://doi.org/10.1007/s10616-020-00405-8
  45. Preliminary study of central nervous system tumors’ prevalence and incidence in Isfahan Province Iran vol.32, pp.1, 2010, https://doi.org/10.1186/s43046-020-00022-8
  46. Epidemiological Study of Malignant Gliomas in Korea Using Nationwide Dataset from 2007 to 2017 vol.36, pp.9, 2010, https://doi.org/10.3346/jkms.2021.36.e68
  47. A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data vol.53, pp.2, 2010, https://doi.org/10.4143/crt.2020.847
  48. Simplified approach for pathological diagnosis of diffuse gliomas in adult patients vol.223, pp.None, 2010, https://doi.org/10.1016/j.prp.2021.153483
  49. Clinicopathological Study of Primary Central Nervous System Tumours - A Descriptive Study in a Tertiary Care Center Hospital of Dakshina Kannada vol.10, pp.36, 2010, https://doi.org/10.14260/jemds/2021/634
  50. A pragmatic diagnostic approach to primary intracranial germ cell tumors and their treatment outcomes vol.10, pp.4, 2021, https://doi.org/10.2217/cns-2021-0012
  51. A Comparison of Epidemiological Characteristics of Central Nervous System Tumours in China and Globally from 1990 to 2019 vol.55, pp.6, 2010, https://doi.org/10.1159/000519463
  52. Epidemiology of Primary Brain Tumors in the Province of Catania during the 2003-2016 Period vol.55, pp.6, 2010, https://doi.org/10.1159/000519512